GLP-1s in the Real World: What Employee Behavior Reveals About Sustainable Obesity Care

SWBA [SouthWest Benefits Association]

GLP-1 medications are rapidly reshaping obesity care, but many employer benefit strategies overlook how these drugs are actually used in the real world. As utilization grows, employers are discovering gaps in care coordination, behavior-change support, and long-term sustainability that can drive up costs without improving outcomes.

This session explores findings from a recent survey on employee GLP-1 utilization, mindset, and drop-off points, and what those insights mean for benefit design. Attendees will walk away with practical guidance on integrating clinical and behavioral interventions, aligning care teams, and building a more cost-effective, comprehensive obesity care strategy.

Complimentary for SWBA members.

More Information, How to Register